Literature DB >> 11829014

Immunohistochemical detection of salivary agglutinin/gp-340 in human parotid, submandibular, and labial salivary glands.

F J Bikker1, A J M Ligtenberg, J E van der Wal, P A M van den Keijbus, U Holmskov, E C I Veerman, A V Nieuw Amerongen.   

Abstract

Salivary agglutinin is a Streptococcus mutans binding protein and a member of the scavenger receptor cysteine-rich superfamily. It is identical to lung gp-340 and brain DMBT1, which possibly play a role in innate immunity and tumor suppression, respectively. The goal of this study was to localize salivary agglutinin in human salivary glands. Two monoclonal antibodies, directed against gp-340, were characterized. mAb 213-1 reacted with sialic acid epitopes and cross-reacted with MUC7. The reaction with mAb 213-6 disappeared after reduction, suggesting that a protein epitope was recognized. In the parotid gland, immunohistochemical labeling with mAb 213-6 was found in the duct cells. In the submandibular gland and labial gland, both serous acini and demilune cells were labeled. In the labial gland, labeling was found at the luminal side of the duct cells. Salivary agglutinin was distinctly localized in salivary glands, but in distinct glandular secretions, no differences in electrophoretic behavior were observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829014

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  11 in total

1.  The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.

Authors:  Martine A Boks; Sabrina T G Gunput; Ilona Kosten; Susan Gibbs; Sandra J van Vliet; Antoon J M Ligtenberg; Yvette van Kooyk
Journal:  J Innate Immun       Date:  2016-04-16       Impact factor: 7.349

2.  Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva.

Authors:  Samuel A Shelburne; Paul Sumby; Izabela Sitkiewicz; Chanel Granville; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

3.  Structural and functional variation within the alanine-rich repetitive domain of streptococcal antigen I/II.

Authors:  Donald R Demuth; Douglas C Irvine
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester.

Authors:  W Kang; O Nielsen; C Fenger; J Madsen; S Hansen; I Tornoe; P Eggleton; K B M Reid; U Holmskov
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

5.  Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection.

Authors:  H Müller; C End; C Weiss; M Renner; A Bhandiwad; B M Helmke; N Gassler; M Hafner; A Poustka; J Mollenhauer; J Poeschl
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

Review 6.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

7.  HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection.

Authors:  Georgetta Cannon; Yanjie Yi; Houping Ni; Earl Stoddard; David A Scales; Donald I Van Ryk; Irwin Chaiken; Daniel Malamud; Drew Weissman
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

8.  gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue.

Authors:  Earl Stoddard; Houping Ni; Georgetta Cannon; Chunhui Zhou; Neville Kallenbach; Daniel Malamud; Drew Weissman
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

9.  The salivary scavenger and agglutinin binds MBL and regulates the lectin pathway of complement in solution and on surfaces.

Authors:  Martin P Reichhardt; Vuokko Loimaranta; Steffen Thiel; Jukka Finne; Seppo Meri; Hanna Jarva
Journal:  Front Immunol       Date:  2012-07-16       Impact factor: 7.561

10.  A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).

Authors:  Jens Madsen; Grith Lykke Sorensen; Ole Nielsen; Ida Tornøe; Lars Thim; Claus Fenger; Jan Mollenhauer; Uffe Holmskov
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.